Literature DB >> 30027471

Recurrent Pulmonary Embolism and Hypersensitivity Pneumonitis Secondary to Aspergillus, in a Compost Plant Worker: Case Report and Review of Literature.

Amos Lal1, Jamal Akhtar2, Soniya Pinto3, Himmat Grewal2, Kevin Martin4.   

Abstract

Activation of blood coagulation pathways as a component of an allergic response has been studied in animal models. In patients with allergic diseases, clot qualities have been noted to be different in terms of denser fibrin clot with reduced plasmin-mediated clot lysis. Correlation between occupational hypersensitivity pneumonitis (HP) with thromboembolic events is scarce in the general patient population. We present a case of a 52-year-old man with recurrent venous thromboembolism with HP secondary to bioaerosol exposure in a compost plant. Biochemical evaluation found no evidence of underlying hypercoagulable state, with only remarkable findings of elevated levels of total serum immunoglobulin E and raised Aspergillus sp. IgG antibodies. The patient decided to change his working environment to one without exposure to compost or other fungal elements. His symptoms and pulmonary function tests gradually improved without any subsequent intervention. The patient chose against the advice of his care providers to discontinue warfarin anti-coagulation that had been recommended for lifelong duration after recurrent pulmonary thromboembolism. At a 4-year follow-up he has remained free of any further episodes of venous thromboembolic events without any anti-coagulation. Repeated imaging studies after cessation of exposure demonstrated clearance of multiple lung nodules and improvement in DLco.

Entities:  

Keywords:  Aspergillus; Computed tomography; Hypersensitivity pneumonitis; Pulmonary embolism; Pulmonary function tests

Mesh:

Substances:

Year:  2018        PMID: 30027471     DOI: 10.1007/s00408-018-0142-6

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  37 in total

Review 1.  Phylogenetic and functional relationships between coagulation and the innate immune response.

Authors:  S M Opal
Journal:  Crit Care Med       Date:  2000-09       Impact factor: 7.598

2.  Occupational hypersensitivity pneumonitis in a baker: a new cause.

Authors:  Mathieu Gerfaud-Valentin; Gabriel Reboux; Julie Traclet; Françoise Thivolet-Béjui; Jean-François Cordier; Vincent Cottin
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

3.  Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease.

Authors:  Victor Kim; Nishant Goel; Jinal Gangar; Huaqing Zhao; David E Ciccolella; Edwin K Silverman; James D Crapo; Gerard J Criner
Journal:  Chronic Obstr Pulm Dis       Date:  2014

4.  Association between atopic diseases and venous thromboembolism: a case-control study in patients aged 45 years or less.

Authors:  A Undas; M Cieśla-Dul; T Drążkiewicz; D P Potaczek; J Sadowski
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

Review 5.  Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors.

Authors:  B van Zaane; E Nur; A Squizzato; V E A Gerdes; H R Büller; O M Dekkers; D P M Brandjes
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

Review 6.  Tissue factor as a link between inflammation and coagulation.

Authors:  Marco Witkowski; Ulf Landmesser; Ursula Rauch
Journal:  Trends Cardiovasc Med       Date:  2015-12-17       Impact factor: 6.677

Review 7.  Epigenetics and T helper 1 differentiation.

Authors:  Thomas M Aune; Patrick L Collins; Shaojing Chang
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

8.  Risk of deep vein thrombosis and pulmonary embolism in asthma.

Authors:  Christof J Majoor; Pieter W Kamphuisen; Aeilko H Zwinderman; Anneke Ten Brinke; Marijke Amelink; Lucia Rijssenbeek-Nouwens; Peter J Sterk; Harry R Büller; Elisabeth H Bel
Journal:  Eur Respir J       Date:  2012-12-20       Impact factor: 16.671

9.  Lung cysts in subacute hypersensitivity pneumonitis.

Authors:  Tomas Franquet; David M Hansell; Taiwo Senbanjo; Martine Remy-Jardin; Nestor L Müller
Journal:  J Comput Assist Tomogr       Date:  2003 Jul-Aug       Impact factor: 1.826

Review 10.  Exposures and health outcomes in relation to bioaerosol emissions from composting facilities: a systematic review of occupational and community studies.

Authors:  Clare Pearson; Emma Littlewood; Philippa Douglas; Sarah Robertson; Timothy W Gant; Anna L Hansell
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2015       Impact factor: 6.393

View more
  5 in total

Review 1.  Current Perspectives of convalescent plasma therapy in COVID-19.

Authors:  Kamal Kant Sahu; Ajay Kumar Mishra; Manish Raturi; Amos Lal
Journal:  Acta Biomed       Date:  2020-11-10

2.  Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study.

Authors:  Małgorzata Sobiecka; Monika Szturmowicz; Katarzyna Lewandowska; Agata Kowalik; Ewa Łyżwa; Katarzyna Zimna; Inga Barańska; Lilia Jakubowska; Jan Kuś; Renata Langfort; Witold Tomkowski
Journal:  BMC Pulm Med       Date:  2021-12-17       Impact factor: 3.317

3.  Antigen avoidance and environmental inhalation challenge for successful diagnosis of fibrotic hypersensitivity pneumonitis mimicking idiopathic pulmonary fibrosis.

Authors:  Yasuhiro Ito; Seiichi Miwa; Hiroshi Hayakawa; Tomoko Oshima; Tatsuru Eihuku; Eriko Iwaizumi; Hisano Ohba; Kaoru Fujita; Miho Kanai; Masahiro Shirai
Journal:  Respir Med Case Rep       Date:  2022-09-13

Review 4.  Trajectory of the COVID-19 pandemic: chasing a moving target.

Authors:  Kamal Kant Sahu; Ajay Kumar Mishra; Amos Lal
Journal:  Ann Transl Med       Date:  2020-06

Review 5.  A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.

Authors:  Marcos A Sanchez-Gonzalez; Dave Moskowitz; Priya D Issuree; George Yatzkan; Syed A A Rizvi; Kenneth Day
Journal:  Infect Chemother       Date:  2020-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.